integrated injectable device reconstitution   Integrated Injectable Device Reconstitution • Published April 2016  •  Catalog no. JDR299F  •  Price US $2,850


The inherent instability of biological drugs is a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed. Alternatively, proteins can be formulated as powders (lyophilization) and must be reconstituted prior to injection. Historically, this was accomplished by including a disposable syringe and diluent vial for manual reconstitution. As the number of drugs developed for self-administration has grown, devices that integrate a reconstitution step with the injection step have gained traction. As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact of specialty devices will increase.

Bar_Graph  Integrated Reconstitution Report Prospectus (Download PDF)

Blue document   Integrated Reconstitution Report Order Form (Download PDF)


Integrated Injectable Device Reconstitution – What You Will Learn

• What is the impact of lyophilized injectable drugs on today’s therapeutic market, how are they   packaged, and who markets them?
• Who are the suppliers of integrated reconstitution devices, and what is their market impact?
• What are the major factors driving the demand for integrated devices for injectable drug reconstitution?
• What is the relative impact of integrated reconstitution systems to OEM or standalone reconstitution devices and how will this change by the end of the decade?
• What are the essential design factors, material selection issues, technologies and market development issues for drug reconstitution systems and devices?
• What is the role of integrated drug reconstitution systems on drug life cycle management?
• What are the significant economic, technology, and regulatory factors affecting the market for   injectable drugs and reconstitution systems in particular?


Integrated Injectable Device Reconstitution – Summary of Contents

Executive Summary

Drug Reconstitution Market Dynamics

Evolution in Device Design
Formulation Factors
Product Specific Device Development
Specialty Injection Device Demand Drivers
Chronic Conditions and Self-Administration
The Growth of Biologicals
Formulation and Dosing
Shifting Patient Demographics
Drug Economics, Safety and Compliance
Device Design and Innovation
Competitive Landscape
Technology Market Drivers

Integrated Devices for Reconstituting Injectables

Dual Chamber Cartridges
Dual Chamber Injectors
Dual Chamber Syringes
Wearable Device Automated Reconstitution System

Dual Chamber Syringe & Injector Device Assessments

Product-Specific Devices
Specialty Devices
OEM Devices

Therapeutic Segments – Market Data & Forecasts

Glycemic Control
Hereditary Conditions
Hormone Replacement
Infectious Disease
Metabolic Conditions
Oncology
Reproductive Health
Other Therapeutic Segments

Market Factors

Device Product Strategies
Device Economics
Product Branding
Direct-to-Consumer Marketing
Managed Care Trends

Company Profiles


Useful Links

The Reconstitution Revolution